Abstract
You have accessJournal of UrologyModerated Poster, Monday, May 22, 2006, 8:00 - 10:00 am1 Apr 2006591: Do Postchemotherapy Patients who Present with an Elevated Serum AFP and Pure Seminoma in the Orchiectomy Specimen Have a Higher Probability of Finding Necrosis only in the Retroperitoneal Lymph Node Dissection (RPLND) Specimen? Matthew D. Peterson, Stephen D.W. Beck, Richard S. Foster, Stephen D. Williams, Lawrence H. Einhorn, Richard Bihrle, and John P. Donohue Matthew D. PetersonMatthew D. Peterson More articles by this author , Stephen D.W. BeckStephen D.W. Beck More articles by this author , Richard S. FosterRichard S. Foster More articles by this author , Stephen D. WilliamsStephen D. Williams More articles by this author , Lawrence H. EinhornLawrence H. Einhorn More articles by this author , Richard BihrleRichard Bihrle More articles by this author , and John P. DonohueJohn P. Donohue More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)32837-4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "591: Do Postchemotherapy Patients who Present with an Elevated Serum AFP and Pure Seminoma in the Orchiectomy Specimen Have a Higher Probability of Finding Necrosis only in the Retroperitoneal Lymph Node Dissection (RPLND) Specimen?." The Journal of Urology, 175(4S), p. 191 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 175Issue 4SApril 2006Page: 191 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Matthew D. Peterson More articles by this author Stephen D.W. Beck More articles by this author Richard S. Foster More articles by this author Stephen D. Williams More articles by this author Lawrence H. Einhorn More articles by this author Richard Bihrle More articles by this author John P. Donohue More articles by this author Expand All Advertisement PDF DownloadLoading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
